FDA Adverse Event Injury Summary report: N

ENDEAVOR SPRINT RX CORONARY STENT SYSTEM

MDR report key: 1901590 · Received November 12, 2010

Report

Report Number
2953200-2010-02232
Event Type
Injury
Date Received
November 12, 2010
Date of Event
May 22, 2012
Report Date
February 14, 2013
Manufacturer
MEDTRONIC CARDIOVASCULAR GALWAY
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

EVALUATION, RESULTS: INHERENT RISK OF PROCEDURE - (CVA/STROKE). (B)(4).

Additional Manufacturer Narrative · 1

(B)(4): EVAL RESULTS: (DISSECTION).

Description of Event or Problem · 1

PATIENT EXPERIENCED STROKE/INTERCRANIAL BLEEDING APPROXIMATELY 51 MONTHS POST INDEX PROCEDURE. INVESTIGATOR INDICATED THAT THIS EVENT WAS NOT RELATED TO THE STUDY STENT.

Description of Event or Problem · 1

AN ENDEAVOR SPRINT RAPID EXCHANGE (RX) DRUG-ELUTING STENT WAS IMPLANTED IN THE MID LAD TO TREAT LESION. ANOTHER ENDEAVOR SPRINT RAPID EXCHANGE (RX) DRUG-ELUTING STENT WAS IMPLANTED OVERLAPPING TO TREAT COMPLICATIONS OF A DISSECTION AFTER THE INITIAL STENT IMPLANTATION. A THIRD STENT WAS IMPLANTED IN THE 1ST OBTUSE MARGINAL TO TREAT ANOTHER TARGET LESION. AT 1 MONTH, 6 MONTHS, 1 YR, 1.5 YRS, 2 YRS AND 2.5 YRS F/U'S PT WAS ASYMPTOMATIC / FREE OF SYMPTOMS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR SPRINT RX CORONARY STENT SYSTEM NIQ MEDTRONIC CARDIOVASCULAR GALWAY NA 0000518121

Patients

Seq Age Sex Outcome Treatment
1 64 YR Required Intervention